AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Vini, L Harmer, C
Citation: L. Vini et C. Harmer, (123)Imaging in the follow-up of differentiated thyroid cancer - Authors reply, CL ONCOL-UK, 13(4), 2001, pp. 314-314

Authors: Nutting, CM Convery, DJ Cosgrove, VP Rowbottom, C Vini, L Harmer, C Dearnaley, DP Webb, S
Citation: Cm. Nutting et al., Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland, RADIOTH ONC, 60(2), 2001, pp. 173-180

Authors: Westbury, C Vini, L Fisher, C Harmer, C
Citation: C. Westbury et al., Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin, THYROID, 10(2), 2000, pp. 171-176

Authors: Landau, D Vini, L A'Hern, R Harmer, C
Citation: D. Landau et al., Thyroid cancer in children: the Royal Marsden Hospital experience, EUR J CANC, 36(2), 2000, pp. 214-220

Authors: Szlosarek, PW Lofts, FJ Pettengell, R Carter, P Young, M Harmer, C
Citation: Pw. Szlosarek et al., Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel, ANTI-CANC D, 11(4), 2000, pp. 275-278

Authors: Vini, L Harmer, C
Citation: L. Vini et C. Harmer, Radioiodine treatment for differentiated thyroid cancer, CL ONCOL-UK, 12(6), 2000, pp. 365-372

Authors: Hyer, SL Vini, L A'Hern, R Harmer, C
Citation: Sl. Hyer et al., Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival, EUR J SUR O, 26(7), 2000, pp. 686-690

Authors: Harmer, C Staples, M Kavanagh, AM
Citation: C. Harmer et al., Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?, CANC CAUSE, 10(5), 1999, pp. 333-337

Authors: Hjiyiannakis, P Mundy, J Harmer, C
Citation: P. Hjiyiannakis et al., Thyroglobulin antibodies in differentiated thyroid cancer, CL ONCOL-UK, 11(4), 1999, pp. 240-244

Authors: Nutting, C Hyer, S Vini, L Harmer, C
Citation: C. Nutting et al., Failure of TSH rise prior to radio-iodine therapy for thyroid cancer: Implications for treatment, CL ONCOL-UK, 11(4), 1999, pp. 269-271

Authors: Vini, L Hyer, S Pratt, B Harmer, C
Citation: L. Vini et al., Management of differentiated thyroid cancer diagnosed during pregnancy, EUR J ENDOC, 140(5), 1999, pp. 404-406

Authors: Cook, AM Vini, L Harmer, C
Citation: Am. Cook et al., Squamous cell carcinoma of the thyroid: outcome of treatment in 16 patients, EUR J SUR O, 25(6), 1999, pp. 606-609

Authors: Ashton, A Balyckyi, J Barton, R Bolger, J Cruickshank, C Davidson, J Dearnaley, D Elyan, S Harmer, C Hoskin, P Jose, C Maitland, L Melville, P Meyer, L Neal, A Regan, J Skeet, O Skelton, L Tait, D Wardle, J Wynne, C Yarnold, J
Citation: A. Ashton et al., 8 Gy single fraction radiotherapy for the treatment of metastatic skeletalpain: randomised comparison with a multifraction schedule over 12 months of patient follow-up, RADIOTH ONC, 52(2), 1999, pp. 111-121

Authors: Mitchell, G Huddart, R Harmer, C
Citation: G. Mitchell et al., Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma, RADIOTH ONC, 50(1), 1999, pp. 33-38

Authors: Vini, L Hyer, S Pratt, B Harmer, C
Citation: L. Vini et al., Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis, POSTG MED J, 75(881), 1999, pp. 169-170
Risultati: 1-15 |